Nanomedicine News

RSS

Novel Molecular Imaging Technology Detects Bladder Cancer with More Accuracy and Sensitivity

Researchers at the Stanford University School of Medicine have developed a new strategy that they say could detect bladder cancer with more accuracy and sensitivity than standard endoscopy methods. Endoscopy refers to a procedure in which surgeons use an instrument equipped with a lens to see inside the patient.

30 Oct 2014

NaturalNano’s ViralProtec Division to Service Growing Demand for Personal Protective Equipment

NaturalNano, Inc. announced today the formation of its ViralProtec Division to service the growing demand for Personal Protective Equipment (PPE). The recent public concern and publicity surrounding the increased risk to caregivers and other responders created by the Ebola virus as well as other public health concerns has raised awareness of the need for additional precautionary steps for those dealing with these issues.

29 Oct 2014

Molecular Devices and Roche Develop High-Throughput Detection System using Ruthenium-Based Nano-TRF Assays

The custom technologies arm of Molecular Devices, a leader in bioanalytical systems for drug discovery, life science research, and bioassay development, has partnered with the Discovery Technologies team at the Roche Innovation Center Basel of Pharma Research and Early Development (pRED) to develop a high-throughput detection system for drug discovery screens employing Roche's proprietary Ruthenium-based nanosecond time resolved fluorescence (Nano-TRF®) assays.

29 Oct 2014

Epigem Contributes Biocompatible Microfluidic Modules for EU-funded Rare Anaemia Treatments Project

Epigem, a high-tech British micro engineering company, has made a major contribution to the EU-funded CoMMiTMenT (Combined Molecular Microscopy for Therapy and Personalised Medication in Rare Anaemia Treatments) project, a significant steptowards the creation of an ‘artificial spleen’.

From Epigem Ltd. 29 Oct 2014

Novavax Presents Ebola GP Recombinant Nanoparticle Vaccine Candidate at 8th Vaccine and ISV Conference

Novavax, Inc. today announced that Gale Smith, Ph.D., Vice President of Vaccine Development at Novavax, presented at the 8th Vaccine and ISV Conference in Philadelphia on Sunday, October 26. Dr. Smith's presentation was titled: 2014 Guinea Ebola Virus Recombinant Glycoprotein (GP) Nanoparticle Vaccine was Highly Immunogenic and Cross-Neutralized 1976 Virus GP Pseudovirus.

From Novavax Inc. 28 Oct 2014

Case Western Receives Grant for Study on Nanotechnology for Treatment of Pediatric Glioma Brain Tumors

Prayers from Maria Children's Glioma Cancer Foundation announced today that it will award its $250,000 Melana Matson Memorial Grant—its third major research grant since 2010—to Case Western Reserve University, Case Comprehensive Cancer Center researchers James Basilion, PhD, Efstathis Karathanasis, PhD, and John Letterio, MD, who are studying the use of nanotechnology to more effectively treat pediatric glioma brain tumors.

28 Oct 2014

USAMRIID Scientists to Evaluate Nanoviricides Anti-Ebola Drug Candidates

NanoViricides, Inc., a nanomedicine company developing anti-viral drugs, announced today that it has executed a CRADA (Collaborative Research and Development Agreement for Material Transfer) with the United States Army Medical Research Institute of Infectious Diseases (USAMRIID).

From NanoViricides, Inc 28 Oct 2014

New Data from Novavax' RSV F-Protein Nanoparticle Vaccine Trial Presented at 8th Vaccine & ISV Congress

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, announced today that Gregory Glenn, M.D., SVP, Research and Development is presenting new immunogenicity data from Novavax' RSV F-Protein Nanoparticle vaccine candidate (RSV F vaccine) clinical trials at the 8th Vaccine & ISV Congress in Philadelphia, PA.

From Novavax Inc. 27 Oct 2014

NanoSIMS Helps Trace How Liver, Brain Cells Store and Metabolize Glycogen

Scientists at EPFL have used a new imaging technique to monitor how glucose, our main energy source, is used in the body. Their findings may have great implications for diseases like diabetes.

27 Oct 2014

Nanoscale Device Can Rapidly Gauge Optimal Dose of Potentially Toxic Cancer Drug

In less than a minute, a miniature device developed at the University of Montreal can measure a patient's blood for methotrexate, a commonly used but potentially toxic cancer drug. Just as accurate and ten times less expensive than equipment currently used in hospitals, this nanoscale device has an optical system that can rapidly gauge the optimal dose of methotrexate a patient needs, while minimizing the drug's adverse effects. The research was led by Jean-François Masson and Joelle Pelletier of the university's Department of Chemistry.

27 Oct 2014

Nanomedicine News

Novel Molecular Imaging Technology Detects Bladder Cancer with More Accuracy and Sensitivity

NaturalNano’s ViralProtec Division to Service Growing Demand for Personal Protective Equipment

Molecular Devices and Roche Develop High-Throughput Detection System using Ruthenium-Based Nano-TRF Assays

Epigem Contributes Biocompatible Microfluidic Modules for EU-funded Rare Anaemia Treatments Project

Novavax Presents Ebola GP Recombinant Nanoparticle Vaccine Candidate at 8th Vaccine and ISV Conference

Case Western Receives Grant for Study on Nanotechnology for Treatment of Pediatric Glioma Brain Tumors

USAMRIID Scientists to Evaluate Nanoviricides Anti-Ebola Drug Candidates

New Data from Novavax' RSV F-Protein Nanoparticle Vaccine Trial Presented at 8th Vaccine & ISV Congress

NanoSIMS Helps Trace How Liver, Brain Cells Store and Metabolize Glycogen

Nanoscale Device Can Rapidly Gauge Optimal Dose of Potentially Toxic Cancer Drug

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting